daftar pustaka

6
DAFTAR PUSTAKA 1. McVary KT, Roehrborn CG, Avins AL, et al. Update on AUA guideline on the management of benign prostatic hyperplasia. J Urol. 2011;185(5):1793-1803. 2. Naslund MJ, Gilsenan AW, Midkiff KD, Bown A, Wolford ET, Wang J. Prevalence of lower urinary tract symptoms and prostate enlargement in the primary care setting. Int J Clin Pract. 2007;61(9):1437-1445. 3. McVary, K, et.al. American Urological Association Guideline: Management of BPH. American Urological Association. 2010; 7. 4. Arlina, P dan Evaria. MIMS Indonesia Petunjuk Konsultasi Edisi 12. PT. Medidata Indonesia; Jakarta. 2013; 212-16 5. Basuki B. Purnomo. Dasar – dasar Urologi. CV. Sagung Seto : Jakarta. 2011 6. Fadlol & Mochtar. Prediksi Volume Prostat pada Penderita Pembesaran Prostat Jinak. Indonesian J of Surgery 2009; XXXIII-4; 139-145

Upload: phrycilia-limen

Post on 17-Jul-2016

218 views

Category:

Documents


1 download

DESCRIPTION

daftar pustaka

TRANSCRIPT

Page 1: Daftar Pustaka

DAFTAR PUSTAKA

1. McVary KT, Roehrborn CG, Avins AL, et al. Update on AUA guideline on the

management of benign prostatic hyperplasia. J Urol. 2011;185(5):1793-1803.

2. Naslund MJ, Gilsenan AW, Midkiff KD, Bown A, Wolford ET, Wang J. Prevalence of

lower urinary tract symptoms and prostate enlargement in the primary care setting. Int J

Clin Pract. 2007;61(9):1437-1445.

3. McVary, K, et.al. American Urological Association Guideline: Management of BPH.

American Urological Association. 2010; 7.

4. Arlina, P dan Evaria. MIMS Indonesia Petunjuk Konsultasi Edisi 12. PT. Medidata

Indonesia; Jakarta. 2013; 212-16

5. Basuki B. Purnomo. Dasar – dasar Urologi. CV. Sagung Seto : Jakarta. 2011

6. Fadlol & Mochtar. Prediksi Volume Prostat pada Penderita Pembesaran Prostat Jinak.

Indonesian J of Surgery 2009; XXXIII-4; 139-145

7. Kapoor, A. Benign Prostatic Hyperplasia (BPH) Management in the Primary Care Settings.

Can J Urol 2012;19(Suppl 1) 10-17

8. Parnham, M, Nijkamp, F. Principles of Immunopharmacology. Springer: Netherlands.

2011; 135-7

9. Rosenberg MT, Miner MM, Riley PA, Staskin DR. STEP: simplified treatment of the

enlarged prostate. Int J Clin Pract. 2010;64(4):482

Page 2: Daftar Pustaka

10. Anderson, CM, Braun CA. Pathophysiology: Functional Alterations in Human Health.

Lippincot William and Wilkins: Philadephia; 2011; 177-18

11. Tubaro, A, Chapple, C. Male LUTS and BPH Made Easy. Springer: New York. 2013; 28-9

12. Roehrborn CG, Sech S, Montoya J, Rhodes T, dan Girman CG Interexaminer reliability

and validity of a three-dimensional model to assess prostate volume by digital rectal

examination. Urology; Philadephia; 2010 57:1087, 2001

13. AUA practice guidelines committee. AUA guideline on management of benign prostatic

hyperplasia. Chapter 1: diagnosis and treatment recommendations. New York; 2010 J Urol

170: 530- 547,

14. Wijanarko S, Gardjito W, Hardjowijoto S, et al.vStudi analitik pengaruh pemasangan

kateter terhadap kadar antigen spesifik prostat dalamvdarah pada pasien hiperplasia prostat

jinakvdengan retensi urine. JURI; 2011; 10: 1-8

15. Brown JS, McNaught KS, Wyman JF, Burgio KL, Harkaway R, Bergner D et al.

Measurement characteristics of voiding diary for use by men and women with overactive

bladder. Urol, 2008; 61:802-809

16. Roehrborn CG, Bartsch G, Kirby R et al. Guidelines for the diagnosis and treatment of

benign prostatic hyperplasia: a comparative, international review. Urology; 2009 58: 642-

650

17. de la Rossette JJMH, Alivizatos G, Madersbacher S, Nording J, Emberton M, dan Sanz CR.

EAU guidelines on benign prostatic Hyperplasia (BPH). Eur Urol; 2009; 40: 256-263

Page 3: Daftar Pustaka

18. Naslund MJ, Gilsenan AW, Midkiff KD, Bown A, Wolford ET, Wang J. Prevalence of

lower urinary tract symptoms and prostate enlargement in the primary care setting. Int J

Clin Pract. 2007;61(9):1437-1445.

19. Lepor H dan Lowe FC. Evaluation and nonsurgical management of benign prostatic

hyperplasia. Dalam: Campbell’s urology, edisi ke 7. editor: Walsh PC, Retik AB, Vaughan

ED, dan Wein AJ. Philadelphia: WB Saunders Co.; 2008; 1337-1378,

20. Javle P, Jenkin SA, Machin DG, dan Parson KF. Grading of benign prostatic obstruction

can predict the outcome of transurethral prostatectomy. J Urol 2009; 160: 1713-1717

21. Jacobsen SJ, Jacobsen DJ, Girman CJ, et al. Treatment for benign prostatic hyperplasia 15

among community dwelling men: the Olmsted County study of urinary symptoms and

healths status. J Urol ; 2009; 162: 1301-1306

22. Clark RV, Hermann DJ. Marked Supression of dihydrotestosterone in men with BPH ny

dutasteride, a dual 5 alphareductase-inhibitor. J Clin Endocronal Metab. 2008; 89(5)- 2179-

2184

23. Steers, WD. 5 alpha-reductase activity in prostate. Urology; 2010; 58: 17-24

24. Gormley, GJ. Stoner, E. The effect of finasteride in men with BPH. N Engl J Med. 2008;

327; 1186-1191

25. Berger, AM, Shuster, JL, Von Romien, JH. Principles and Palliative Care of Supportive

Oncology. Lippincot William and Wilkis; Philadelphia. 2009; 282-84

26. Thompson, R. Advanced Therapy of Prostate Disease. B.C Decker. Hamilton. 2005; 188-

90

Page 4: Daftar Pustaka

27. Choi, J. Ikeguchi, E. Laser Prostatectomy: A Check up Promise. Rev Urol. Summer; 2008;

1(3): 170–176.

28. Rubenstein, J. Transurethral Microwave Thermotherapy of Prostate. Medscape. 2013

29. Chapple, C. Prostatic Obstruction. Springer-Verlac; London; 2009; 185-87

30. Rahardjo D. Prostat: kelainan-kelainan jinak, diagnosis dan penanganan. 1st ed. Asian

Medical; Jakarta; 201-3.